Cite
HARVARD Citation
Lik Yuen Chan, H. et al. (n.d.). IDDF2019-ABS-0169 A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results. Gut. pp. A142-A143. [Online].